Guselkumab Recruiting Phase 4 Trials for Psoriatic Arthritis Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04929210 | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease |